期刊文献+

RNA干扰技术体外抑制低氧诱导因子-1α及血管内皮细胞生长因子表达的研究 被引量:1

Study on suppression of hypoxia inducible factor-la and vascular endothelial growth factor expression by siRNA targeting hypoxia inducible factor-1α
原文传递
导出
摘要 目的研究正常氧及低氧环境下,pSUPER^h1-siHIF-1α。真核表达载体对低氧诱导因子-1α(HIF-1α)表达的抑制效果及由此引起的血管内皮细胞生长因子(VEGF)表达的差异。方法构建pSUPER^h1-siHIF-1α真核表达载体,并建立pSUPER^h1-siHIF-1α稳定转染细胞系。采用半定量逆转录聚合酶链反应(RT-PCR)法,筛选HIF-1α mRNA抑制效率最高的细胞系。然后将其与对照细胞在正常氧(20%O2)及低氧环境(1%O2)下培养,采用半定量RT-PCR、免疫印迹法及ELISA技术检测正常氧及低氧环境下pSUPER^h1-siHIF-1α对HIF-1α及VEGF表达的抑制效果。结果低氧环境下,pSUPER^h1-siHIF-1α可明显抑制HIF-1α和VEGFmRNA及蛋白质的表达。而正常氧环境下,pSUPER^h1-siHIF-1α虽可明显下调HIF-1αmRNA表达水平,但对VEGF mRNA和分泌型蛋白表达水平无明显抑制效果。结论低氧环境下,pSUPER^h1-siHIF-1α能显著抑制HIF-1α的表达,且下调其下游基因VEGF的表达。因此,pSUPER^h1-siHIF-1α可能为视网膜新生血管的基因治疗提供新的途径。(中华眼科杂志,2007,43:1028-1035) Objective To evaluate suppression efficiency of hypoxia inducible factor-1α (HIF-1α) specific siRNA derived from recombinant plasmid (pSUPER^h1-siHIF-1α) on both HIF-1α mRNA and protein expression and concomitant downregulation of expression of downstream anglogenic factor vascular endothelial growth factor (VEGF). Methods Stable pSUPER^h1-siHIF-1α expression cell lines were constructed by transient transfection of pSUPER^h1-siHIF-1α eukaryotic expression vector, followed by puromycin selection. Stable expression pSUPER^h1-siHIF-1α cell line with highest HIF-1α inhibition efficiency determined by reverse transcription-polymerase chain reaction ( RT-PCR ) was cultured under nomoxia ( 20% 02 ) and hypoxia conditions (1% 02) together with control cells. RT-PCR, western blot and ELISA were used to measure inhibition ability of pSUPER^h1-siHIF-1α on HIF-1α and VEGF expression. Results Compared to the control cells, both mRNA and protein level of HIF-1α and VEGF were dramatically decreased by pSUPER^h1-siHIF-1α under hypoxia conditions. Under sufficient oxygen supply situation, HIF-1α mRNA level was downregulated by pSUPER^h1-siHIF-1α, but pSUPER^h1-siHIF-1α did not cause suppression of VEGF expression. Conclusions pSUPER^h1-siHIF-1α could decrease HIF-1α expression under both nomoxia and hypoxia conditions. VEGF expression was downregulated under hypoxia conditions only. Consequently, pSUPER^h1-siHIF-1α might be a powerful tool for the inhibition of retinal neovascularization. (Chin J Ophthalmol, 2007,43:1028-1035)
出处 《中华眼科杂志》 CAS CSCD 北大核心 2007年第11期1028-1035,共8页 Chinese Journal of Ophthalmology
基金 国家自然科学基金资助项目(030471853)
关键词 核蛋白质类 DNA结合蛋白质类 血管内皮生长因子A RNA干扰 Nuclear proteins DNA-dinding proteins Vascular endothelial growth factorA RNA interference
  • 相关文献

参考文献15

  • 1Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and 02- regulated gene expression. FASEB J ,2002,16 : 1151-1162.
  • 2Ozaki H,Yu AY,DelIa N,et al. Hypoxia inducible factor-lalpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci, 1999,40 : 182- 189.
  • 3Pe'er J, Shweiki D, hin A, et al. Hypoxia-indueed expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest, 1995,72 : 638-645.
  • 4pepper MS, Mandriota S, Vassalli JD, et al. Angiogenesis regulating cytokines:activities and interactions. Curr Top Microbiol Immunol, 1996,213:31-67.
  • 5Noel A, Maillard C, Rocks N ,et al. Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol, 2004, 57:577-584.
  • 6Robinson GS, Pierce EA, Rook SL, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA, 1996,93:4851-4856.
  • 7Bainbridge JW, Mistry A, De Alwis M, et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther,2002 ,9 :320-326.
  • 8Le Gat L,Gogat K, Bouquet C, et al. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy. Gene Ther, 2003,10:2098-2103.
  • 9Carcia C, Bartsch DU, Rivero ME, et al. Efficacy of prinomastat (AG3340):a matrix metalloprotease inhibitor in treatment of retinal neovascularization. Curr Eye Res,2002,24:33-38.
  • 10Hitoshi T, Shinji K, Hisayuki S, et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci,2003,44:393-402.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部